Real-time commercial impact of clinical data from every major oncology congress
What’s the commercial impact of business-critical clinical trial data?
When you work with Breaking Data, you will…
- know which abstracts oncologists are most interested in
- know what oncologists think about clinical data in real time
- know the commercial impact of new clinical trial data
- have a senior leadership-ready report post congress
Prostate Cancer Rapid Impact Report: ASCO, 2019
After every major congress, a deck shows up in my inbox that helps me understand how newly released data are going to impact oncologists’ behaviors. The executive summary, charts, graphs and quotes are very helpful for my team and me.
-Snr. Director of Marketing, Oncology
Melanoma Rapid Impact Report: ASCO, 2019
A lot of vendors ‘cover’ meetings … Breaking Data is different because they help me understand the meeting
–Director of Marketing, Oncology
Adoptive Cellular Therapy Rapid Impact Report: ASCO, 2019
Immediately after the abstracts are available online, Breaking Data helps us identify what’s important and why. From there, our questions emerge. And those questions are answered by their panel of oncologists who attend the congress.
-Director of Market Research, Oncology